Zenlabs Ethica Files FY26 Annual Report & AGM Notice

Zenlabs Ethica Ltd has filed its Annual Report for the financial year 2025-26, along with the Notice of the 33rd Annual General Meeting (AGM). The report details the company's operations, including its WHO-GMP certified pharmaceutical business, trading and distribution activities across domestic and international markets, and its position within the Preet Remedies Group. The AGM is scheduled for September 29, 2026, to adopt the audited financial statements for FY26. The company emphasizes its focus on expanding product reach, strengthening market presence through strategic alliances, and maintaining quality compliance.